As effector CD8 T cells engage tumor cells in the TME, they become dysfunctional over time and lose the ability to produce effector molecules such as cytokines and cytotoxic granules (Barber et al., 2006; Wherry, 2011). This evidence concerns the gene CD8A and neoplasm.